Barrier dysfunction in nasal epithelium contributes to persistent inflammation in long COVID - 05/01/26
on behalf of the
P4O2 consortium
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Abstract |
Background |
Long COVID (LC) is characterized by persistent symptoms associated with chronic inflammation and immune dysregulation, but the local tissue mechanisms driving these processes remain poorly understood.
Objective |
Given that the nasal epithelium is the primary entry and infection site for SARS-CoV-2, we aimed to investigate its role in LC and its potential contribution to systemic immune activation.
Methods |
We analyzed nasal epithelial samples and peripheral blood from participants in the Precision Medicine for More Oxygen (P4O2) COVID-19 cohort, post–COVID-19 individuals, and healthy controls. We assessed epithelial barrier integrity, evaluated wound healing, and explored cytokine profiles. Transcriptomic analysis was performed via RNA sequencing. Blood innate lymphoid cells (ILCs) were phenotyped by flow cytometry and stimulated in vitro for functional assays.
Results |
Among a subgroup of LC patients, nasal epithelial cells showed impaired barrier function, reduced expression of ZO-1 and occludin and exaggerated sensitivity to viral triggers. Despite faster wound closure, the epithelial repair was reduced. The LC nasal epithelium exhibited increased cytokine production, including IL-1β and transcriptomic signatures of inflammation, including upregulation of interferon pathways. Furthermore, we found that TFs ATF3 and EGR1 were downregulated in LC. Elevated IL-1β levels in nasal epithelium promoted ILC activation and plasticity toward IFN-γ–producing ILCs in blood.
Conclusion |
While multiple organ systems are implicated in LC, our findings identified nasal epithelial dysfunction in a subgroup of LC patients and chronic activation as potential contributors to systemic immune dysregulation. The IL-1β–IFN-γ axis represents a novel targetable pathway that may support precision therapies for LC.
Le texte complet de cet article est disponible en PDF.Key words : Long COVID, epithelial-immune cross talk, epithelial barrier dysfunction, precision medicine, postviral condition
Abbreviations used : ALI, COVID-19, FACS, HC, ILC, LC, P4O2, PC, RNA-Seq, SARS-CoV-2, TEER, TF, TJ, ZO-1
Plan
Vol 157 - N° 1
P. 203-216 - janvier 2026 Retour au numéro
Article précédent
- Proteomic profiling and machine learning for endotype prediction in chronic rhinosinusitis
- Christina Morgenstern, Tina J. Bartosik, Karina N. Bayer, Nicholas J. Campion, Florian Frommlet, Katharina Gangl, Fana A. Kidane, Linda Liu, Klaus Schmetterer, Victoria Stanek, Aldine Tu, Klemens Ungersbäck, Mohammed Zghaebi, Sven Schneider, Julia Eckl-Dorna
- Caspase 1–deficient humans survive into late adulthood despite dramatically lower canonical inflammasome activity
- John Dominy, Christopher Koch, Christelle Arnold, Vinney George, Maleeha Zaman Khan, Shareef Khalid, Aneeqa Bano, Muhammad Rehan Mian, Wafa Gul, Muhammad Bilal Liaqat, Lubna Kamani, Nazish Butt, Marium Dahar, Namra Saqib, Anjum Jalal, Shahid Abbas, Riffat Sultana, Musfireh Siddiqeh, Syed Shahzaib Raza, Muhammad Haroon, Asadullah Khan, Javed Iqbal, Faizan Aslam, Khalid Parvez Babar, Muhammad Sadik Memon, Ambreen Muddassir, Syed Asif Raza Zaidi, Mateen Akram, Aflak Rasheed, Saima Naz Mohsin, Samreen Bugti, Tariq Mehmood, Abdul Lateef Rodeni, Shahid Mukhtar, Tahir Rasool, Adil Mahmood, Muhammad Noor Wazir, Sheraz Jamal Khan, Muhammad Asghar Khan, Rahmat Ghaffar, Sanaullah Jan, Noor Ul Hadi, Asif Rasheed, Karine Jeanneau, Thomas Le Meur, Agnes Chassang, Jonas Zierer, Richard M. Siegel, Ursula Bodendorf, Allan Gurtan, Danish Saleheen
Bienvenue sur EM-consulte, la référence des professionnels de santé.